<DOC>
	<DOCNO>NCT01210456</DOCNO>
	<brief_summary>Contrast-Induced Acute Kidney Injury ( CIAKI ) define absolute increase serum creatinine equal 0.3mg/dl ( ≥ 26.4 μmol/l ) , percentage increase serum creatinine equal 50 % ( 1.5-fold baseline ) within 48 hour intravascular contrast administration absence alternative cause , reduction urine output document oliguria less 0.5 ml/kg per hour six hour . It common cause new hospital-acquired renal insufficiency . The occurrence CIAKI may influence pre-existing renal insufficiency , diabetic nephropathy , dehydration , congestive heart failure , concurrent administration nephrotoxic drug , dose type contrast medium use . Previous study show independent effectiveness several agent prevent CIAKI . Even , hydration crucial preventing CIAKI . Since CIAKI presume cause free radical generation , N-Acetylcysteine , potent free radical scavenger , show effective preventing nephropathy . At time , free radical formation promote acidic environment , bicarbonate , alkalinize renal tubular fluid , show reduce renal involvement . These day , study show hydration sodium bicarbonate plus N-Acetylcysteine effective safe prevention CIAKI . In study , bicarbonate use alkalinize renal tubular fluid hydration . However , want hydration , use saline want alkalinize renal tubular fluid , might use bicarbonate bolus injection . Actually , bicarbonate hydration prepare sterile preparation room hospital , cumbersome procedure increase cost . This one reason bicarbonate hydration use become common wide clinical application . In past issue , though differs depend level renal dysfunction , probability CIAKI 8-33 % hydration administer , 5-15 % hydration N-Acetylcysteine administer , 1.8-1.9 % bicarbonate N-Acetylcysteine administer . Thus , hypothesize combination N-Acetylcysteine bicarbonate play complementary role prevent contrast-induced nephropathy . This rational study .</brief_summary>
	<brief_title>Efficacy Trial N-Acetylcysteine Sodium Bicarbonate Prevention Contrast-Induced Acute Kidney Injury</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>serum creatinine equal 1.1mg/dL procedure use contrast medium congestive heart failure serum creatinine le 1.1mg/dl allergy contrast medium preexist dialysis emergency catheterization recent exposure contrast within 2 day study refuse entry study PTRA dialysis procedure</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>Contrast Media</keyword>
	<keyword>Acute Kidney Injury</keyword>
	<keyword>N-Acetylcysteine</keyword>
	<keyword>Bicarbonate</keyword>
</DOC>